Independent evidence review for high-stakes market decisions

Know what deserves action — before you commit.

Ascendo turns fragmented evidence around markets, targets and theses into a clear decision view: what is supported, what remains uncertain, what to verify next and what to drop.

Traceable evidence · Explicit uncertainty · Human-controlled judgment

Start with the decision in front of you

Choose the smallest paid format that can make the next move clearer. Each route has an explicit scope, evidence boundary and decision output.

Market entry / GTM

Find a credible route into a market

Clarify the buyer, trigger, urgency, budget logic and proof boundaries before a market-entry narrative turns into committed GTM work.

  • Wedge Fit Check — 1500 EUR
  • Wedge Validation Sprint — scoped after fit
See the Wedge Fit Check scope

Target / investment thesis

Get an outside view of a target or thesis

Separate supported signals, contradictions and proof gaps before more time, diligence effort or capital is committed to the case.

  • Target Triage Brief — 900 EUR
  • Thesis Market Map — 2500–5000 EUR
See the Target Triage scope

Existing evidence / claim set

Stress-test an existing memo or claim set

Review what the evidence actually supports, where confidence is premature and what must be verified before the material reaches a board, IC or outbound motion.

  • Thesis Confidence Review — 1500–2900 EUR
See the review options

A proportional decision view

Enough clarity for the next step — without pretending to know more than the evidence allows

The output is not a polished narrative designed to make every route look attractive. It separates the current evidence state from the next decision.

1

What is supported

Claims and signals that have enough traceable evidence to inform the next move.

2

What remains uncertain

Contradictions, missing context and conclusions that would overstate the available evidence.

3

What to verify next

The smallest set of questions or primary checks that can materially change the decision.

4

What not to act on

Routes, claims or assumptions that should not receive more attention yet.

Why this matters now

Research is faster. Confidence is not.

AI and agentic research tools can map a market and synthesize public material quickly. Speed does not remove missing buyer context, contradictory evidence, timing risk or weak proof.

Ascendo provides the independent judgment layer after synthesis: source-traced conclusions, explicit uncertainty and a bounded next step.

Inspect the work

The evidence standard is visible before you engage

The open CEE Agritech intelligence package is a broader format than a scoped diagnostic. It shows how Ascendo separates sources, claims, proof gaps, timing signals and uncertainty in a difficult market.

Inspect the open proof asset →

Analytical control stays human

  • Critical claims remain connected to reviewable sources.
  • Observed facts and analytical interpretation stay separate.
  • Unknowns and evidence limits are stated rather than hidden.
  • Final framing and escalation decisions remain human-controlled.

Start with the smallest useful decision

Send a sanitized outline of the market, target or thesis and the decision it needs to inform. Scope, price and confidential handling are confirmed before work starts.

Choose a scoped engagement →